Healthcare benefits

Amazon, American Express and Ikea are among the employers offering enviable perks to employees.

Employers should ask themselves how they are handling the Cadillac tax, if there is financial mischief occurring with pharmacy rebates and if they should amend plan documentation.

Commentary about Trumpcare, health savings accounts and leave laws were among the most popular items this year.

Here’s what employers including IBM, Mastercard and TD Bank did this year to redefine their employee benefit packages.

Employers should work to prevent the spread of illness in the office by offering shots at on-site locations and dispelling common misconceptions about the vaccine.

With a new administration came big changes in the benefits industry and these stories were must-reads during a busy year.

Akamai's Sarah Sardella, BP’s Cliff York, Accenture’s Julie Wilkes and SurveyMonkey’s Becky Cantieri were honored for improving employee health, retirement and work-life balance.

A costly revamp is needed to make vision behind Aetna deal reality.

These industry pioneers are creating products to meet evolving needs of employers and employees.

Akamai's Sarah Sardella, BP’s Cliff York, Accenture’s Julie Wilkes and SurveyMonkey’s Becky Cantieri were honored for improving employee health, retirement and work-life balance.

These industry pioneers, awarded by EBN this year, are creating products to meet evolving needs of employers and employees.

The last month of the year saw a bevy of new hires and promotions inside companies that operate in the employee benefit arena.

Jeff Bezos has eyed the pharmacy business for years without plunging in. The upside may be too big to ignore.

From retirement to healthcare, these are the must-watch slideshows from 2017.

Mitch McConnell says the compromise tax bill from House and Senate negotiators will end the health law’s requirement that all individuals buy insurance or pay a fine.

The new year will see a continuation of the trends from 2017 that have affected employers — but with a sharp focus on insurance company acquisitions and opioid regulations.

Nonalcoholic fatty liver disease is on the rise among younger generations, and can have astronomical cost effects for both employees and firms.

The last month of the year saw a bevy of new hires and promotions inside companies that operate in the employee benefit arena.

The U.S. drug industry’s main lobbying group said it filed a lawsuit challenging the constitutionality of a California law meant to make drug prices more transparent.

Nonalcoholic fatty liver disease is on the rise among younger generations, and can have astronomical cost effects for both employees and firms.